Background Ventricular arrhythmias are the most common consequences of structural and functional heart diseases, but cases with no evident pathology are also observed. A parameter indicating asymptomatic circulatory failure could support decisions related to possible treatment of ventricular arrhythmias. Hypothesis The study objective was the evaluation of N‐terminal prohormone brain natriuretic peptide (NT‐proBNP) levels in children with ventricular arrhythmias and an attempt to determine if this parameter may be used for diagnosis and prognosis of ventricular arrhythmias. Material and methods The study population was comprised of 36 children age 5 to 17.5 years old with idiopathic ventricular arrhythmias (Group B) graded mild or potentially malignant; 29 patients with mild ventricular arrhythmias were included into Group B1; and 7 patients with potentially malignant cases into Group B2. In all the patients, NT‐proBNP assays were performed. Results The NT‐proBNP levels in Groups B, B1, B2 and the control group (Group K) were as follows: 41.5 ± 15.1 pg/mL, 35.5 ± 18.5 pg/mL, 66.3 ± 24.9 pg/mL and 31.5 ± 15.1 pg/mL, respectively. Between the groups with and without arrhythmias (Group B vs Group K), no statistically significant differences in NT‐proBNP levels were found. However, markedly higher NT‐proBNP levels were shown in the children with potentially malignant arrhythmias (Group B2) compared to the patients with mild arrhythmias (B1) and the control group (Group K). Conclusions The level of NT‐proBNP increases with the severity of ventricular arrhythmia. NT‐proBNP assays can be helpful for diagnosing and grading the severity of ventricular arrhythmias. Copyright © 2009 Wiley Periodicals, Inc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.